rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-30
|
pubmed:abstractText |
The benefits of antihypertensive (AH) drugs on the risks of major cardiovascular outcomes have been demonstrated in clinical trials. However, approximately half of hypertensive patients do not adhere well to their prescribed AH therapy in actual practice. The purpose of this study was to assess the impact of adherence to AH agents on the incidence of cerebrovascular disease (CD) in real-world practice.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1524-4628
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
213-20
|
pubmed:meshHeading |
pubmed-meshheading:19038916-Aged,
pubmed-meshheading:19038916-Aged, 80 and over,
pubmed-meshheading:19038916-Antihypertensive Agents,
pubmed-meshheading:19038916-Cardiovascular Diseases,
pubmed-meshheading:19038916-Case-Control Studies,
pubmed-meshheading:19038916-Cerebrovascular Disorders,
pubmed-meshheading:19038916-Comorbidity,
pubmed-meshheading:19038916-Dyslipidemias,
pubmed-meshheading:19038916-Female,
pubmed-meshheading:19038916-Humans,
pubmed-meshheading:19038916-Hypertension,
pubmed-meshheading:19038916-Logistic Models,
pubmed-meshheading:19038916-Male,
pubmed-meshheading:19038916-Middle Aged,
pubmed-meshheading:19038916-Patient Compliance,
pubmed-meshheading:19038916-Patient Education as Topic,
pubmed-meshheading:19038916-Risk Factors,
pubmed-meshheading:19038916-Risk Reduction Behavior,
pubmed-meshheading:19038916-Sex Distribution
|
pubmed:year |
2009
|
pubmed:articleTitle |
Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention.
|
pubmed:affiliation |
Faculty of Pharmacy, PO Box 6128, Centre-Ville Station, Montréal, Québec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|